The Campylobacter Resource Facility uses genome-based technologies such as next-generation sequencing, microarrays and mutants to study the pathogenesis of this microorganism.

Explaining trends and inequalities in cancer survival at regional, national and international level, including in socio-economic, racial and ethnic groups of the population.

Strongly encourages research and collaboration fostering integration of mental health with the care of other communicable and non-communicable diseases.

Promoting and undertaking high quality research to develop and deepen historical understanding in the field of public health and health services policy. 

Bringing a public health approach to prevention of violence in childhood and adolescence, and to improving child protection internationally.

The LSHTM Clinical Trials Unit is accredited by the UK Clinical Research Collaboration. We conduct high-quality, high-impact trials in the UK and internationally.

Group of eye health organisations from several Commonwealth countries working together to deliver an exciting, integrated, five-year programme of fellowships, research and technology which aims, over the long-term, to strengthen eye health systems and quality of eye care throughout the Commonwealth.

Research for policy reform on international disease control in Southeast Asia and beyond.

Driving clinical & biomedical research to improve the recognition, diagnosis and treatment of ME/CFS.